Emergent and J&J settle dispute over COVID vaccine supplies

Emergent BioSolutions said Monday that Johnson & Johnson has agreed to pay $50 million to settle claims related to a terminated COVID-19 vaccine deal. The company’s shares rose about 2 per cent in extended trading.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO